Showing results (461-470 of 830) with videos related to
Sort By:
Pageof 83
Pharmacogenetics|April 1, 1995
High yield expression of functionally active human liver CYP2D6 in yeast cellsE Y Krynetski, V L Drutsa, I E Kovaleva, et al.Pharmacogenetics|April 1, 1995
The mephenytoin (cytochrome P450 2C 19) and dextromethorphan (cytochrome P450 2D6) polymorphisms in Saudi Arabians and FilipinosD A Evans, P Krahn, N NarayananPharmacogenetics|April 1, 1995
Phenotyping of CYP2C19 with enantiospecific HPLC-quantification of R- and S-mephenytoin and comparison with the intron4/exon5 G-->A-splice site mutationJ Brockmöller, K L Rost, D Gross, et al.Pharmacogenetics|June 1, 1993
Human peripheral lymphocytes as indicators of microsomal epoxide hydrolase activity in liver and lungC J Omiecinski, L Aicher, R Holubkov, et al.Pharmacogenetics|January 1, 1995
The CYP2A gene subfamily: species differences, regulation, catalytic activities and role in chemical carcinogenesisP Fernandez-Salguero, F J GonzalezPharmacogenetics|January 1, 1995
Assessment of cancer susceptibility in humans by use of genetic polymorphisms in carcinogen metabolismS Ikawa, F Uematsu, K Watanabe, et al.Pharmacogenetics|January 1, 1995
Implication of nitric oxide synthase in carcinogenesis: analysis of the human inducible nitric oxide synthase geneH Esumi, T Ogura, Y Kurashima, et al.Pharmacogenetics|February 1, 1993
Characterization of a human cell line expressing high levels of cDNA-derived CYP2D6B W Penman, J Reece, T Smith, et al.Pharmacogenetics|December 1, 1996
Human phenol sulfotransferase pharmacogenetics: STP1 gene cloning and structural characterizationR B Raftogianis, C Her, R M WeinshilboumPharmacogenetics|December 1, 1996
S-mephenytoin hydroxylation phenotype and CYP2C19 genotype among EthiopiansI Persson, E Aklillu, F Rodrigues, et al.Pageof 83